Inhibition of Candida rugosa Lipase by Berberine and Structurally Related Alkaloids, Evaluated by High-Performance Liquid Chromatography

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 9, 1999, Pages 1557-1562

  Grippa, Eleonora ^a   Valla, Roberto ^a   Battinelli, Lucia ^a   Mazzanti, Gabriela ^a   Saso, Luciano ^a   Silvestrini, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Berberine; Candida rugosa lipase; HPLC; Inhibition; Sanguinarine

Indexed keywords

ALKALOID; ANTIINFECTIVE AGENT; BERBERINE; ENZYME INHIBITOR; FATTY ACID; TRIACYLGLYCEROL LIPASE;

ARTICLE; CANDIDA; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; SKIN;

ALKALOIDS; ANTI-INFECTIVE AGENTS; BERBERINE; CANDIDA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; FATTY ACIDS; HUMANS; LIPASE; SKIN;

EID: 0033194160     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.1557     Document Type: Article

References (47)

1. Simons, J. W., van Kampen, M.D., Riel, S., Gotz, F., Egmond, M. R., and Verheij, H. M., Cloning, purification and characterisation of the lipase from Staphylococcus epidermidis—comparison of the substrate selectivity with those of other microbial lipases. Eur. J. Biochem., 253, 675-83 (1998).
2. Gribbon, E. M., Cunliffe, W. J., and Holland, K. T., Interac-tion of Propionibacterium acnes with skin lipids in vitro. J. Gen. Microbiol., 139, 1745-51 (1993).
3. Das, S. K. and Banerjee, A. B., Phospholipids of Trichophyton rubrum. Sabouraudia, 12, 281-6 (1974).
4. Muhsin, T. M., Aubaid, A. H., and al-Duboon, A. H., Extracellular enzyme activities of dermatophytes and yeast isolates on solid media. Mycoses, 40, 465-9 (1997).
5. Slomiany, B. L., Murty, V. L., Piotrowski, J., and Slomiany A., Effect of antiulcer agents on the physicochemical properties of gastric mucus. Symp. Soc. Exp. Biol., 43, 179-91 (1989).
6. Slomiany, B. L. and Slomiany, A., Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J. Clin. Gastroenterol., 14, 81 14-21 (1992).
7. Engel, E., Guth, P. H., Nishizaki, Y., and Kaunitz, J. D., Barrier function of the gastric mucus gel. Am. J. Physiol., 269, G994-9 (1995).
8. Lichtenberger, L. M. The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol., 57, 565-83 (1995).
9. Slomiany, B. L., Piotrowski, J., and Slomiany, A., Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases. Am. J. Gastroenterol., 87, 595-9 (1992).
10. Slomiany, B. L., Murty, V. L., Piotrowski, J., and Slomiany, A., Gastroprotective agents in mucosal defense against Helicobacter pylori. Gen. Pharmacol., 25, 833-41 (1994).
11. Sung, J. J., Leung, V. K., Chung, S. C., Ling, T. K., Suen, R., Cheng, A. F., and Li, A. K., Triple therapy with sucralfate, tetracycline, and metronidazole for Helicobacter pylori-associated duodenal ulcers. Am. J. Gastroenterol., 90, 1424-7 (1995).
12. Smoot, D. T., How does Helicobacter pylori cause mucosal damage? Direct mechanisms. Gastroenterology, 113, S31-4 (1997).
13. Shimura, S., Tsuzuki, W., Kobayashi, S., and Suzuki, T., Inhibitory effect on lipase activity of extracts from medicinal herbs. Biosci. Biotechnol. Biochem., 56, 1478-1479 (1992).
14. Benjamin, S. and Pandey, A., Candida rugosa lipases: molecular biology and versatility in biotechnology. Yeast, 14, 1069-87 (1998).
15. Jaeger, K. E., Ransac, S., Dijkstra, B. W., Colson, C., van Heuvel, M., and Misset, O., Bacterial lipases. FEMS Microbiol. Rev., 15, 29-63 (1994).
16. Maurich, V., Moneghini, M., Zacchigna, M., Pitotti, A., and Lencioni, E., High-performance liquid chromatographic assay of pancreatic lipase activity. J. Pharm. Biomed. Anal., 9, 427-31 (1991).
17. Tallarida, R. J. and Murray, R. B., Manual of pharmacologic calculations with computer programs. Springer, New York (1986).
18. Lotti, M., Monticelli, S., Montesinos, J. L., Brocca, S., Valero, F., and Lafuente, J., Physiological control on the expression and secretion of Candida rugosa lipase. Chem. Phys. Lipids, 93, 143-8 (1998).
19. Holmquist, M., Insights into the molecular basis for fatty acyl specificities of lipases from Geotrichum candidum and Candida rugosa. Chem. Phys., Lipids, 93, 57-66 (1998).
20. Moore, E. W., Celic, L., and Ostrow, J. D., Interactions between ionized calcium and sodium taurocholate: bile salts are important buffers for prevention of calcium-containing gallstones. Gastroenterology, 83, 1079-89 (1982).
21. Pablo, G., Hammons, A., Bradley, S., and Fulton, J. E. Jr., Characteristics of the extracellular lipases from Corynebacteri-um acnes and Staphylococcus epidermidis. J. Invest. Dermatol., 63, 231-8 (1974).
22. Smith, J. L. and Alford, J. A., Inhibition of microbial lipases by fatty acids. Appl. Microbiol., 14, 699-705 (1966).
23. Demant, E. J., Fatty acid inhibition of triacylglycerol lipase in mitochondrial fractions from baker’s yeast. FEBS Lett., 85, 109-13 (1978).
24. Kaminsky, S., Smith, L. J., and D’Souza, S. W., Human gastric lipase. Effects of fatty acid and bovine serum albumin on in vitro activity. Scand. J. Clin. Lab. Invest., 48, 583-7 (1988).
25. Shalita, A. R. and Wheatley, V., Inhibition of pancreatic lipase by tetracyclines. J. Invest. Dermatol., 54, 413-5 (1970).
26. Hassing, G. S., Inhibition of Corynebacterium acnes lipase by tetracycline. J. Invest. Dermatol., 56, 189-92 (1971).
27. Weaber, K., Freedman, R., and Eudy, W. W., Tetracycline inhibition of a lipase from Corynebacterium acnes. Appl. Microbiol., 21, 639-42 (1971).
28. Puhvel, S. M. and Reisner, R. M., Effect of antibiotics on the lipases of Corynebacterium acnes in vitro. Arch. Dermatol., 106, 45-9 (1972).
29. Mates, A., Inhibition of Staphylococcus aureus lipase by tetracycline. J. Invest. Dermatol., 60, 150-2 (1973).
30. Webster, G. F., McGinley, K. J., and Leyden, J. J., Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. Br. J. Dermatol., 104, 453-7 (1981).
31. Unkles, S. E. and Gemmell, C. G., Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. An-timicrob. Agents Chemother., 21, 39-43 (1982).
32. Dougherty, J. M., McCulley, J. P., Silvany, R. E., and Meyer, D. R., The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest. Ophthalmol. Vis. Sci., 32, 2970-5 (1991).
33. Durckheimer, W., Tetracyclines: chemistry, biochemistry, and structure-activity relations. Angew. Chem. Int. Ed. Engl., 14, 721-34 (1975).
34. Hellgren, L. and Vincent, J., Erythromycin stearate in acne vulgaris: its effect on the skin surface lipids and on the activity of purified pancreatic lipase. Dermatologica, 156, 105-10 (1978).
35. Lee, W. L., Shalita, A. R., Suntharalingam, K., and Fikrig, S. M., Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect. Immun., 35, 71-8 (1982).
36. Leyden, J. J., Therapy for acne vulgaris. N. Engl. J. Med., 336, 1156-62 (1997).
37. Higaki, S., Hasegawa, Y., Morohashi, M., Sakamoto, K., and Yamagishi, T., The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes. Nippon Hifuka Gakkai Zasshi (in Japanese), 100, 883-6 (1990).
38. Higaki, S., Nakamura, M., Morohashi, M., Hasegawa, Y., and Yamagishi, T., Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes. J. Dermatol., 23, 310-4 (1996).
39. Schmeller, T., Latz-Bruning, B., and Wink, M., Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry, 44, 257-66 (1997).
40. Khin-Maung U, Myo Khin, Nyunt-Nyunt Wai, and Tin U, Clinical trial of high-dose berberine and tetracycline in cholera. J. Di-arrhoeal Dis. Res., 5, 184-7 (1987).
41. Uchiyama, T., Kamikawa, H., and Ogita, Z., Anti-ulcer effect of extract from phellodendri cortex. Yakugaku Zasshi (in Japanese), 109, 672-6 (1989).
42. Beliaeva, T. N., Bulychev, A. G., Lasskaia, O. E., and Semenova, E. G., Effect of sanguiritrine on the functional activity of fibroblast lysosomes. Vopr. Med. Khim., 36, 16-8 (1990).
43. Balanyk, T. E., Sanguinarine: comparisons of antiplaque/antigingivitis reports. Clin. Prev. Dent., 12, 18-25 (1990).
44. Grenby, T. H., The use of sanguinarine in mouthwashes and toothpaste compared with some other antimicrobial agents. Br. Dent. J., 178, 254-8 (1995).
45. Brondz, I., Nordbo, H., and Scheie, A. A., Detection of microbial-derived fatty acids in carious dentin by gas chromatography and gas chromatography-mass spectrometry. J. Chromatogr. B, 700, 255-60 (1997).
46. Cai, S., Simionato, M. R., Mayer, M. P., Novo, N. F., and Zelante, F., Effects of subinhibitory concentrations of chemical agents on hydrophobicity and in vitro adherence of Streptococcus mutans and Streptococcus sanguis. Caries Res., 28, 335-41 (1994).
47. Walterova, D., Ulrichova, J., Valka, I., Vicar, J., Vavreckova, C., Taborska, E., Harjrader, R. J., Meyer, D. L., Cerna, H., and Simanek, V. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Univ. Palacki. Olomuc. Fac. Med., 139, 7-16 (1995).